【参】六角形画像(NEWS)

H1

NEWS

パンくずリスト

ホーム > Kidswell Bio Corporation > NEWS

★IR：カテゴリメニュー

タブV2

All
IR Library
Topics

2021/01/05

IR Library

Interview video of Masaharu Tani, CEO, has been released at Sessa TV.
2020/11/09

IR Library

Summary of Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2021 [PDF：596KB]
2020/11/09

IR Library

FY2020 2Q IR Meeting Information [PDF：3730KB]
2020/09/18

IR Library

Announcement of Application for Approval of Manufacturing and Sales in Japan for biosimilar in the Ophthalmic Area [PDF：254KB]
2020/08/20

IR Library

Announcement of Joint Research Agreement with Hokkaido University and Spinal Injuries Center for Non-Union Fractures [PDF：255KB]
2020/07/15

IR Library

New business alliance with Dojin Group to accelerate research and development of regenerative medicine products by using SHED and expand SHED-related business [PDF：631KB]
2020/05/25

IR Library

Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2020 [PDF：480KB]
2020/05/25

IR Library

FY2019 IR Meeting Information [PDF：1450KB]
2020/04/08

IR Library

Announcement of completion of issuance of the 3rd series of convertible bond with stock acquisition rights and the 10th series of stock acquisition rights [PDF：336KB]
2020/03/23

IR Library

[Presentation] Establishment of manufacturing process for the master cell bank and business alliance with Mochida Pharma, and Financing for driving JRM-001 [PDF：763KB]
2020/03/16

IR Library

Announcement of Establishment of Manufacturing Process for Master Cell Bank Based on the Business Partnership with NIKON CORPORATION

[PDF：122KB]
2020/03/05

IR Library

Announcement of Joint Research Agreement with Oita University for Peripheral Nerve Paralysis [PDF：176KB]
2020/03/05

IR Library

Announcement of Joint Research Agreement with Nagoya University for Spinal Cord Injury [PDF：146KB]
2020/02/19

IR Library

End of Observation Period for the Last Patient in Phase III Clinical Trial of Biosimilar Product for Ophthalmic Treatment in Japan Developed with Senju Pharmaceutical Co., Ltd.

[PDF：128KB]
2020/02/17

IR Library

[Presentation] Announcement of Acquisition of Shares of Japan Regenerative Medicine Co., Ltd. [PDF：763KB]
2020/02/17

IR Library

[Document] Announcement of Acquisition of Shares of Japan Regenerative Medicine Co., Ltd. [PDF：182KB]
2020/02/14

IR Library

Announcement of Business Alliance Agreement with DOJIN GROUP Co, Ltd. for business development in regenerative medicine and healthcare area [PDF：124KB]
2020/02/05

IR Library

FY2019 3Q IR Meeting Information [PDF：1828KB]
2020/02/05

IR Library

Summary of Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2020
[PDF：309KB]
2020/01/30

IR Library

Signed alliance agreement with Eil for business development in regenerative medicine and healthcare area [PDF：115KB]
2020/01/22

IR Library

Announcement of Joint Research Agreement for Cerebral Palsy with Three Institutes

[PDF：189KB]
2020/01/21

IR Library

Announcement of Joint Research Agreement for New Antibodies with MabGenesis Inc.

[PDF：182KB]
2020/01/06

IR Library

Announcement of Joint Development Agreement with Sapporo Medical University

[PDF：271KB]
2019/12/02

IR Library

Announcement of Joint Development Agreement of Aflibercept Biosimilars with Kishi Kasei Co., Ltd.

[PDF：319KB]
2019/11/22

topics

Announcement on Series B Funding by Heartseed Inc.
2019/11/05

IR Library

FY2019 2Q IR Meeting Information [PDF：1547KB]
2019/11/05

IR Library

Summary of Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2020 [PDF：341KB]
2019/11/05

IR Library

Announcement of the Appointment of Scientific Advisor and Establishment of Scientific Advisory Board [PDF：243KB]
2019/11/05

IR Library

Announcement of Academia-industry Collaboration with Showa University School of Medicine for a Development of Treatments in Cell Therapy Field using Stem Cells from Human Exfoliated Deciduous Teeth [PDF：138KB]
2019/10/16

IR Library

Acquisition and Cancellation of the 6th Series of Stock Acquisition Rights (Private Placement) [PDF：130KB]
2019/10/07

IR Library

Signed a Contract for Sale of Stem Cells from Human Exfoliated Deciduous Teeth between Kidswell Bio Corporation Co., Ltd.and Summit Pharmaceuticals International Corporation.

[PDF：151KB]
2019/09/30

IR Library

New Financing Arrangements and Investment in Heartseed Inc.

[PDF：863KB]
2019/09/30

IR Library

Announcement of Investment in Regenerative Medicine Venture Company Heartseed Inc.

[PDF：116KB]
2019/09/20

IR Library

Announcement of Receiving Manufacturing and Marketing Approval for Darbepoetin Alpha Biosimilars in Japan

[PDF：111KB]
2019/09/18

IR Library

Announcement of Joint Research Agreement with Gifu Pharmaceutical University for a Development of Treatments for an Ophthalmologic Disease using Stem Cells from Human Exfoliated Deciduous Teeth [PDF：107KB]
2019/09/10

IR Library

Announcement of Joint Research Agreement with Showa University School of Medicine for a Development of Treatments for Bone-related Diseases using Stem Cells from Human Exfoliated Deciduous Teeth [PDF：108KB]
2019/08/19

IR Library

Company Research and Analysis Report released from FISCO Ltd. [PDF：1345KB]
2019/08/08

IR Library

Announcement of Execution of Incorporation-type Company Split of Consolidated Subsidiary [PDF：169KB]
2019/08/05

IR Library

Announcement of Accounting Extraordinary Gains on the Sale of Investment Securities and Extraordinary Losses [PDF：144KB]
2019/08/05

IR Library

Summary of Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2020 [PDF：304KB]
2019/05/10

IR Library

FY2018 IR Meeting Information [PDF：1157KB]
2019/05/10

topics

Notice of Relocation of Head Office Function, Relocation of Tokyo Office, and Integration of Subsidiaries office [PDF：137KB]
2019/05/10

topics

Announcement of signing a joint research and development agreement with ORTHOREBIRTH for cleft lip/cleft palate [PDF：198KB]
2019/05/10

IR Library

Summary of Non-consolidated Financial Results for the Fiscal Year Ended March 31, 2019 [PDF：289KB]
2019/03/12

topics

Notice of Resolutions at the Extraordinary General Shareholders Meeting [PDF：297KB]
2019/02/28

topics

Completion of the enrollment of the final patient in the Phase III study for ophthalmologic biosimilar [PDF：78KB]
2019/02/05

topics

FY2018 3Q IR Meeting Information [PDF：2408KB]
2019/02/05

IR Library

Summary of Non-consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2019 [PDF：343KB]
2019/01/31

topics

GTS and Senju sign a licensing agreement with Ocumension Therapeutics on biosimilar in ophthalmologic field [PDF：93KB]
2019/01/17

topics

[Presentation] Execution of Share Exchange Agreement and Conversion of Advanced Cell Technology and Engineering into Wholly-Owned Subsidiary of Kidswell Bio Corporation [PDF：1833KB]

Previous
1
2
3
4
5
Next

2024/09/05

IR Library

1Q FY2024 update from OMEGA Investment [PDF：892KB]
2024/08/14

IR Library

[Presentation] Financial Results for 1Q FY 2024 [PDF：1388KB]
2024/08/14

IR Library

Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2025 [PDF：222KB]
2024/06/18

IR Library

Business alliance agreement for co-development of biosimilars [PDF：104KB]
2024/06/11

IR Library

Announcement of the Conclusion of an Outsourcing Agreement to Strengthen Collaboration with Biotech Ventures [PDF：131KB]
2024/05/30

IR Library

4Q FY2023 update from OMEGA Investment [PDF：818KB]
2024/05/14

IR Library

[Presentation] Financial Results for the FY 2023 [PDF：1786KB]
2024/05/14

IR Library

Summary of Financial Results for the Fiscal Year Ended March 31, 2024 (Non-consolidated) [PDF：212KB]
2024/03/25

IR Library

Announcement of revisions to FY2023 financial guidance [PDF：78KB]
2024/03/18

IR Library

Announcement of the loan arrangement from Japan Finance Corporation [PDF：74KB]

1
2
3
4
5
6
7
8
9
10
Next

2019/11/22

topics

Announcement on Series B Funding by Heartseed Inc.
2019/05/10

topics

Notice of Relocation of Head Office Function, Relocation of Tokyo Office, and Integration of Subsidiaries office [PDF：137KB]
2019/05/10

topics

Announcement of signing a joint research and development agreement with ORTHOREBIRTH for cleft lip/cleft palate [PDF：198KB]
2019/03/12

topics

Notice of Resolutions at the Extraordinary General Shareholders Meeting [PDF：297KB]
2019/02/28

topics

Completion of the enrollment of the final patient in the Phase III study for ophthalmologic biosimilar [PDF：78KB]
2019/02/05

topics

FY2018 3Q IR Meeting Information [PDF：2408KB]
2019/01/31

topics

GTS and Senju sign a licensing agreement with Ocumension Therapeutics on biosimilar in ophthalmologic field [PDF：93KB]
2019/01/17

topics

[Presentation] Execution of Share Exchange Agreement and Conversion of Advanced Cell Technology and Engineering into Wholly-Owned Subsidiary of Kidswell Bio Corporation [PDF：1833KB]
2019/01/17

topics

[Announcement] Execution of Share Exchange Agreement and Conversion of Advanced Cell Technology and Engineering into Wholly-Owned Subsidiary of Kidswell Bio Corporation [PDF：348KB]
2018/09/28

topics

Submission of New Drug Application in Japan of Darbepoetin alfa Biosimilar [PDF：169KB]

1
2
3
4
Next